Real-World Evidence: Explaining The Current State Of The FDA’s RWE Program

Clinical Leader | February 25, 2019

This article will guide you through the program and what it means for drug developers and explain the potential that real-world data (RWD) offers in developing RWE to significantly and safely accelerate the drug approval process.

Read more ›